Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri scMRD Assay for AML. Learn More
X
Scientific presentation

Single-cell DNA-Seq publication roundup: what did they uncover at MD Anderson Cancer Center, UCSF, Memorial Sloan Kettering, and Stanford Medicine?


Kelly Kaihara, PhD
Description

Single-cell sequencing methods have enabled multi-modal characterization of tumor heterogeneity to yield novel insights into tumor evolution, therapeutic response, and resistance in hematological disorders. Dr. Kelly Kaihara, from Mission Bio, reviews recent publications from MD Anderson Cancer Center, UCSF, Memorial Sloan Kettering, and Stanford Medicine that use the Mission Bio Tapestri Platform for single-cell analysis. See how researchers are using this groundbreaking technology to study single-cell multi-omics of DNA and Protein for the first time in a high-throughput fashion.



VIEW


Scientific presentation
AML Single-cell Multi-omics MRD (scMRD) and the Horizon of Clinical Utility
Aaron Llanso
AMP 2022 (2022)
Scientific presentation
Molecular Analysis of Acute Myeloid Leukemia in Morphologic Remission
Sanam Loghavi, MD
AMP 2022 (2022)
Scientific presentation
Considerations, Strategies, and Advances in Early Drug Development to Mitigate Clinical Holds and Achieve Successful CGT Outcomes
Azadeh Golipour, PhD, AVROBIO
J. Kelly Ganjei, AmplifyBio
Scott R. Burger, MD, Advanced Cell and Gene Therapy
Matthew Cato
(2022)
Scientific presentation
Overview on Mission Bio’s Applications
Simone Formisano
Mission Bio EU Heme Symposium (2022)
REQUEST QUOTE